EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immune escape mechanisms revealed by multifunctional nanoprobes targeting PD‐L1 in hepatic cancer progression

Yiteng Meng, Liwen Jing, Yeda Chen, Shenggang Zhan, Feng Xiong, Wenbiao Chen

VIEW · 2026-06 · 7 (3)

DOI: 10.1002/viw.20250078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift VIEW, online erschienen am 22.03.2026. Verfasst von Yiteng Meng und 5 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) often arises from liver cirrhosis, yet real‐time, noninvasive monitoring of immune escape during this transition remains limited. We developed a multifunctional biomimetic nanoprobe (ICGB@Apt) by conjugating a programmed death‐ligand 1 (PD‐L1)–specific DNA aptamer (selected via Cell–SELEX) onto an indocyanine green/BMS‐684 polymer, enabling in vivo imaging and immune modulation. In CCl 4 ‐induced mouse models progressing from cirrhosis to HCC and in complementary in vitro 3D co‐culture systems, ICGB@Apt preferentially accumulated in tumor tissue, dynamically visualized PD‐L1, and mitigated disease progression. The probe enhanced CD8 + T‐cell activity (IFN‐γ and granzyme B), reduced fibrosis and tumor burden, and outperformed non‐aptamer controls (Apt+ICG or ICGB alone). Knockdown experiments and RNA‐seq highlighted the centrality of the programmed death‐1 (PD‐1)/PD‐L1 axis; immune deconvolution implicated CD8 + T cells, follicular helper T cells, and M0 macrophages in the cirrhosis‐to‐cancer shift. The nanoprobes showed favorable biocompatibility and enabled longitudinal tracking of primary and metastatic lesions. Together, these findings establish ICGB@Apt as a PD‐L1–targeted platform that simultaneously monitors and counteracts immune escape, offering translational potential for early detection and immunotherapy guidance in HCC.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Meng, Y., Jing, L., Chen, Y., Zhan, S., Xiong, F., & Chen, W. (2026). Immune escape mechanisms revealed by multifunctional nanoprobes targeting PD‐L1 in hepatic cancer progression. VIEW, 7(3). https://doi.org/10.1002/viw.20250078

Vancouver

Meng Y, Jing L, Chen Y, Zhan S, Xiong F, Chen W. Immune escape mechanisms revealed by multifunctional nanoprobes targeting PD‐L1 in hepatic cancer progression. VIEW. 2026;7(3). doi:10.1002/viw.20250078

BibTeX
@article{Meng2026,
  author = {Meng, Yiteng and Jing, Liwen and Chen, Yeda and Zhan, Shenggang and Xiong, Feng and Chen, Wenbiao},
  title = {Immune escape mechanisms revealed by multifunctional nanoprobes targeting PD‐L1 in hepatic cancer progression},
  journal = {VIEW},
  year = {2026},
  volume = {7},
  number = {3},
  doi = {10.1002/viw.20250078}
}
Kostenlos starten →